This inventor holds 1 USPTO granted patent. Top assignee: Rudjer Boskovic Institute. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Branko Alic: Innovator in Tumor Treatment
Introduction
Branko Alic is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of tumors. His innovative work has led to the development of compounds that show promise in cancer therapy.
Latest Patents
Branko Alic holds a patent for "Analogues of 1,3-bis(4-nitrophenyl)triazenes, their pharmaceutically acceptable salts and N-acyl derivatives for tumour treatment." This invention refers to analogues of 1,3-bis(4-nitrophenyl)triazenes, which exhibit cytotoxicity at very low concentrations (IC0.22 to 12.8 µM) and demonstrate good solubility. These compounds can be utilized in the treatment of tumor patients either as standalone drugs or in combination with other cytostatics.
Career Highlights
Branko Alic is affiliated with the Ruđer Bošković Institute, where he conducts his research and development work. His career is marked by a commitment to advancing medical science and improving treatment options for cancer patients.
Collaborations
Branko collaborates with esteemed colleagues, including Maja Osmak and Slovenko Polanc, who contribute to his research endeavors and help in the advancement of his innovative projects.
Conclusion
Branko Alic's work in developing novel compounds for tumor treatment showcases his dedication to improving healthcare outcomes. His contributions to the field of pharmaceuticals are invaluable and highlight the importance of innovation in medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile